The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis to settle an avalanche of litigation, according to a report filed Friday by a federal mediator.
Feb 20, 2022
0
9
"Appealing to logic and values to break cemented habits is not enough. Now, when we're building so many new urban environments, there is a unique opportunity to make the environment promote pro-environmental behaviors," says ...
Oct 19, 2021
0
1
The US Justice Department has challenged a plan that would dissolve Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the country's opioid crisis, while shielding its founders from lawsuits.
Sep 16, 2021
0
25
Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the US opioid crisis, will be dissolved under a plan approved by a federal judge on Wednesday.
Sep 2, 2021
0
6
In recent years, hospital charges and Medicare payments for patients with hip fractures have increased much more rapidly than charges and payments for orthopedic surgeons, reports a study in the Journal of Orthopedic Trauma.
Mar 17, 2021
0
0
US drugmaker Purdue Pharma filed a new bankruptcy plan that would see its founders the Sackler families pay an additional $1.5 billion to settle the company's role in the devastating opioid crisis that has killed half a million ...
Mar 16, 2021
0
4
(HealthDay)—Purdue Pharma pleaded guilty to three criminal charges linked to the Oxycontin maker's role in the nation's opioid epidemic.
Nov 26, 2020
0
7
US drugmaker Purdue Pharma pleaded guilty to three criminal charges over its production and sales of the prescription opioid Oxycontin, which stoked a nationwide addiction crisis, the Justice Department announced Wednesday.
Oct 21, 2020
0
2
Authorities say nine students from a Florida charter school ate marijuana-infused candy and were hospitalized with stomach pains.
Sep 9, 2019
0
3
Three drug companies will pay a total of nearly $70 million to California to settle charges of delaying the sale of generic drugs to keep brand-name drug prices high, the state's attorney general said Monday.
Jul 31, 2019
0
0
